Uncovering new genes related to heart failure
PhD ceremony: Ms. B. Lu, 16.15 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Uncovering new genes related to heart failure
Promotor(s): prof. W.H. van Gilst
Faculty: Medical Sciences
Heart failure is characterized by a reduced cardiac output, resulting in decreased exercise capacity, shortness of breath, fatigue and edema. Prognosis for heart failure is poor with a mortality rate of approximately 50% within 5 years. Heart failure is a chronic disease and with the ageing population the incidence of heart failure will increase. Among others, ischemic heart disease, hypertension and valve disease, are the main causes of heart failure development. All these pathologic conditions lead to a series of molecular, cellular and interstitial changes in the heart which are known as cardiac remodeling. Cardiomyocyte hypertrophy (growth) is one of the main remodeling processes and the main topic of this thesis. In this thesis we describe the investigation of gene expression changes that are associated with heart failure development and cardiomyocyte hypertrophy. Heart tissue from healthy rats was compared with those that had developed heart failure. Moreover, expression was analyzed in pure cardiomyocytes cultured in dishes with and without hypertrophic stimulation. This investigation yielded a robust set of hypertrophy/ and heart failure associated genes, including known heart failure genes, but also some which have not previously been linked to heart failure. One identified unknown gene, Dhrs7c, was further investigated. It was shown to be mainly expressed in heart and muscle and importantly its expression was also altered in human heart biopsies from heart failure patients. This confirms that we have generated a dataset that should prove invaluable for a further analysis of human heart failure.
Last modified: | 13 March 2020 12.59 a.m. |
More news
-
27 August 2024
UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling
Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...
-
17 July 2024
Veni-grants for ten researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.
-
16 July 2024
Medicine still subjects to male bias
Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.